Europe Drug Delivery Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024
In this region, Europe Drug Delivery Market is projected to reach USD 536.12 billion by 2024 from USD 305.54 billion in 2016, at a CAGR of 7.3% in the forecast period 2017 to 2024.
Based on geography, the Europe Drug Delivery market is segmented into 11 geographical regions, such as,
Johnson & Johnson is going to dominate the drug delivery market following with F. Hoffmann-La Roche Ltd and Novartis AG, along with others such as
The Europe drug delivery market is segmented into 8 types on the basis of route of administration, namely oral, injectable, topical, ophthalmic, nasal, pulmonary, implantable, transmucosal.
On the basis of end users, the market is classified into hospitals, clinics, home healthcare, community centres, and others.
On the basis of distribution channel, the market is segmented into direct tenders, hospital pharmacies, pharmacy stores, and online pharmacies.
Based on geography, the Europe Drug Delivery market is segmented into 11 geographical regions, such as,
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Turkey
- Belgium
- Netherlands
- Switzerland and
- Rest Of Europe.
Johnson & Johnson is going to dominate the drug delivery market following with F. Hoffmann-La Roche Ltd and Novartis AG, along with others such as
- Pfizer
- Bayer AG
- GlaxoSmithKline plc.
- Merck & Co.
- Sanofi
- Antares Pharma
- 3M
- Becton Dickinson and Company
- Nemera, Cima Labs, Inc.
- Dali Medical Devices
- Alkermes
- Foamis
- Ypsomed
- Skyepharma AG
- Valeant Pharmaceuticals
- DSM Biomedical
- Catalent, Inc.
The Europe drug delivery market is segmented into 8 types on the basis of route of administration, namely oral, injectable, topical, ophthalmic, nasal, pulmonary, implantable, transmucosal.
On the basis of end users, the market is classified into hospitals, clinics, home healthcare, community centres, and others.
On the basis of distribution channel, the market is segmented into direct tenders, hospital pharmacies, pharmacy stores, and online pharmacies.
1. INTRODUCTION
1.1. OVERVIEW OF EUROPE DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
3.1.2. GROWTH IN THE DEVELOPMENT OF BIOLOGICS
3.1.3. TECHNOLOGICAL DEVELOPMENT
3.2. RESTRAINTS
3.2.1. RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS
3.3. OPPORTUNITIES
3.3.1. RISING ACCEPTANCE OF SELF ADMINISTERING DRUGS
3.3.2. RISING DEMAND FOR BIOSIMILARS AND GENERIC DRUGS
3.3.3. TREND OF MERGER AND ACQUISITIONS, AND COLLABORATIONS
3.3.4. FOCUS ON PATIENT NEEDS
3.3.5. DEVELOPING AND NEW EMERGING REVENUE POCKETS
3.4. THREATS
3.4.1. PRODUCT RECALLS
3.4.2. STRINGENT REGULATORY AND HIGH PRICING
3.4.3. PATENT EXPIRY AND PATENT CLIFF
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION
6.1. OVERVIEW
6.2. EUROPE ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.2.1. EUROPE SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.2.2. EUROPE LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.2.3. EUROPE SEMI-SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.3. EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.3.1. EUROPE NEBULIZERS MARKET, BY PRODUCT TYPE
6.4. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.4.1. EUROPE INJECTABLE DRUG DELIVERY DEVICES, BY PRODUCT TYPE
6.4.2. EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET
6.4.3. EUROPE SELF-INJECTION DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE
6.4.4. EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE
6.5. EUROPE OPHTHALMIC DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.5.1. EUROPE OCUULAR DRUG DELIVERY FORMULATIONS MARKET, BY FORM
6.5.2. EUROPE OCCULAR DRUG DELIVERY DEVICES, BY PRODUCT TYPE
6.6. EUROPE NASAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.7. EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.7.1. EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE
6.7.2. EUROPE TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE
6.7.2.1. EUROPE SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE
6.7.2.2. EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE
6.7.2.3. EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE
6.8. EUROPE IMPLANTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9. EUROPE TRANSMUCOSAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9.1. EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9.2. EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
7. EUROPE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
7.1. OVERVIEW
8. EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER
8.1. OVERVIEW
9. EUROPE DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. EUROPE DRUG DELIVERY MARKET
9.3. GERMANY DRUG DELIVERY MARKET
9.4. U.K. DRUG DELIVERY DEVICES MARKET
9.5. FRANCE DRUG DELIVERY MARKET
9.6. ITALY DRUG DELIVERY DEVICES MARKET
9.7. RUSSIA DRUG DELIVERY DEVICES MARKET
9.8. TURKEY DRUG DELIVERY MARKET
9.9. SWITZERLAND DRUG DELIVERY MARKET
9.10. BELGIUM DRUG DELIVERY DEVICES MARKET
9.11. SPAIN DRUG DELIVERY DEVICES MARKET
9.12. NETHERLANDS DRUG DELIVERY MARKET
10. REST OF EUROPE DRUG DELIVERY MARKET
11. EUROPE DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: EUROPE
12. COMPANY PROFILES
12.1. JOHNSON & JOHNSON
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. PFIZER, INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. 3M
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ANTARES PHARMA, INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. MERCK & CO.
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
13. RELATED REPORTS
1.1. OVERVIEW OF EUROPE DRUG DELIVERY MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2. MARKET SEGMENTATION
2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS
3. MARKET OVERVIEW
3.1. DRIVERS
3.1.1. RISING PREVALENCE OF CHRONIC DISEASES
3.1.2. GROWTH IN THE DEVELOPMENT OF BIOLOGICS
3.1.3. TECHNOLOGICAL DEVELOPMENT
3.2. RESTRAINTS
3.2.1. RISK OF NEEDLE-STICK INJURIES AND SIDE EFFECTS
3.3. OPPORTUNITIES
3.3.1. RISING ACCEPTANCE OF SELF ADMINISTERING DRUGS
3.3.2. RISING DEMAND FOR BIOSIMILARS AND GENERIC DRUGS
3.3.3. TREND OF MERGER AND ACQUISITIONS, AND COLLABORATIONS
3.3.4. FOCUS ON PATIENT NEEDS
3.3.5. DEVELOPING AND NEW EMERGING REVENUE POCKETS
3.4. THREATS
3.4.1. PRODUCT RECALLS
3.4.2. STRINGENT REGULATORY AND HIGH PRICING
3.4.3. PATENT EXPIRY AND PATENT CLIFF
4. EXECUTIVE SUMMARY
5. PREMIUM INSIGHTS
6. EUROPE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION
6.1. OVERVIEW
6.2. EUROPE ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.2.1. EUROPE SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.2.2. EUROPE LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.2.3. EUROPE SEMI-SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.3. EUROPE PULMONARY DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.3.1. EUROPE NEBULIZERS MARKET, BY PRODUCT TYPE
6.4. EUROPE INJECTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.4.1. EUROPE INJECTABLE DRUG DELIVERY DEVICES, BY PRODUCT TYPE
6.4.2. EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET
6.4.3. EUROPE SELF-INJECTION DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE
6.4.4. EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE
6.5. EUROPE OPHTHALMIC DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.5.1. EUROPE OCUULAR DRUG DELIVERY FORMULATIONS MARKET, BY FORM
6.5.2. EUROPE OCCULAR DRUG DELIVERY DEVICES, BY PRODUCT TYPE
6.6. EUROPE NASAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.7. EUROPE TOPICAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.7.1. EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE
6.7.2. EUROPE TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE
6.7.2.1. EUROPE SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE
6.7.2.2. EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE
6.7.2.3. EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE
6.8. EUROPE IMPLANTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9. EUROPE TRANSMUCOSAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9.1. EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
6.9.2. EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET, BY PRODUCT TYPE
7. EUROPE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL
7.1. OVERVIEW
8. EUROPE DRUG DELIVERY DEVICES MARKET, BY END USER
8.1. OVERVIEW
9. EUROPE DRUG DELIVERY MARKET, BY GEOGRAPHY
9.1. OVERVIEW
9.2. EUROPE DRUG DELIVERY MARKET
9.3. GERMANY DRUG DELIVERY MARKET
9.4. U.K. DRUG DELIVERY DEVICES MARKET
9.5. FRANCE DRUG DELIVERY MARKET
9.6. ITALY DRUG DELIVERY DEVICES MARKET
9.7. RUSSIA DRUG DELIVERY DEVICES MARKET
9.8. TURKEY DRUG DELIVERY MARKET
9.9. SWITZERLAND DRUG DELIVERY MARKET
9.10. BELGIUM DRUG DELIVERY DEVICES MARKET
9.11. SPAIN DRUG DELIVERY DEVICES MARKET
9.12. NETHERLANDS DRUG DELIVERY MARKET
10. REST OF EUROPE DRUG DELIVERY MARKET
11. EUROPE DRUG DELIVERY MARKET, COMPANY SHARE
11.1. COMPANY SHARE ANALYSIS: EUROPE
12. COMPANY PROFILES
12.1. JOHNSON & JOHNSON
12.1.1. COMPANY OVERVIEW
12.1.2. REVENUE ANALYSIS
12.1.3. PRODUCT PORTFOLIO
12.1.4. RECENT DEVELOPMENTS
12.2. PFIZER, INC.
12.2.1. COMPANY OVERVIEW
12.2.2. REVENUE ANALYSIS
12.2.3. PRODUCT PORTFOLIO
12.2.4. RECENT DEVELOPMENTS
12.3. 3M
12.3.1. COMPANY OVERVIEW
12.3.2. REVENUE ANALYSIS
12.3.3. PRODUCT PORTFOLIO
12.3.4. RECENT DEVELOPMENTS
12.4. ANTARES PHARMA, INC.
12.4.1. COMPANY OVERVIEW
12.4.2. REVENUE ANALYSIS
12.4.3. PRODUCT PORTFOLIO
12.4.4. RECENT DEVELOPMENTS
12.5. MERCK & CO.
12.5.1. COMPANY OVERVIEW
12.5.2. REVENUE ANALYSIS
12.5.3. PRODUCT PORTFOLIO
12.5.4. RECENT DEVELOPMENTS
13. RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2016 48
TABLE 2 LIST OF FDA APPROVED GENERICS, IN 2016 52
TABLE 3 MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY MARKET, 2016 54
TABLE 4 PATENT EXPIRY OF DRUGS, 2015-2017 56
TABLE 5 EUROPE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2015 – 2024 (USD BILLION) 65
TABLE 6 EUROPE ORAL DRUG DELIVERY MARKET, BY FORM, 2015 – 2024 (USD BILLION) 66
TABLE 7 EUROPE SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 68
TABLE 8 EUROPE LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 70
TABLE 9 EUROPE SEMI-SOLID ORAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 71
TABLE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 72
TABLE 11 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 72
TABLE 12 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2015 – 2024 (USD BILLION) 73
TABLE 13 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 73
TABLE 14 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2015 – 2024 (USD BILLION) 74
TABLE 15 EUROPE SELF INJECTION DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 74
TABLE 16 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 75
TABLE 17 EUROPE PULMONARY DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 77
TABLE 18 EUROPE NEBULIZERS DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 79
TABLE 19 EUROPE INJECTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 81
TABLE 20 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 82
TABLE 21 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2015 – 2024 (USD BILLION) 85
TABLE 22 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 85
TABLE 23 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2015 – 2024 (USD BILLION) 86
TABLE 24 EUROPE SELF INJECTION DRUG DELIVERY DEVICES MARKET,
BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 89
TABLE 25 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 91
TABLE 26 EUROPE OPHTHALMIC DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 92
TABLE 27 EUROPE OCCULAR DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 94
TABLE 28 EUROPE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 94
TABLE 29 EUROPE SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 95
TABLE 30 EUROPE OCCULAR DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 97
TABLE 31 EUROPE NASAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 99
TABLE 32 EUROPE TOPICAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 100
TABLE 33 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE,2015 – 2024 (USD BILLION) 102
TABLE 34 EUROPE TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 103
TABLE 35 EUROPE SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 104
TABLE 36 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 106
TABLE 37 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 107
TABLE 38 EUROPE IMPLANTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 109
TABLE 39 EUROPE TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 111
TABLE 40 EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 112
TABLE 41 EUROPE OTHER TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 114
TABLE 42 EUROPE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 116
TABLE 43 EUROPE DRUG DELIVERY MARKET, BY END USER, 2015 – 2027 (USD BILLION) 119
TABLE 44 EUROPE DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) 124
TABLE 45 EUROPE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2015 – 2024 (USD BILLION) 126
TABLE 46 EUROPE ORAL DRUG DELIVERY MARKET, BY FORM, 2015 – 2024 (USD BILLION) 127
TABLE 47 EUROPE SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 127
TABLE 48 EUROPE LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 128
TABLE 49 EUROPE SEMI-SOLID ORAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 128
TABLE 50 EUROPE INJECTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 129
TABLE 51 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 129
TABLE 52 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2015 – 2024 (USD BILLION) 130
TABLE 53 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 130
TABLE 54 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2015 – 2024 (USD BILLION) 131
TABLE 55 EUROPE SELF INJECTION DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 131
TABLE 56 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 132
TABLE 57 EUROPE OPHTHALMIC DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 132
TABLE 58 EUROPE OCCULAR DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 133
TABLE 59 EUROPE OPHTHALMIC DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 133
TABLE 60 EUROPE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 134
TABLE 61 EUROPE SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 134
TABLE 62 EUROPE NASAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 135
TABLE 63 EUROPE TOPICAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 135
TABLE 64 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 136
TABLE 65 EUROPE TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 136
TABLE 66 EUROPE SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 137
TABLE 67 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY TYPE, 2015 – 2024 (USD BILLION) 137
TABLE 68 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY TYPE, 2015 – 2024 (USD BILLION) 138
TABLE 69 EUROPE IMPLANTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 138
TABLE 70 EUROPE TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 139
TABLE 71 EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 139
TABLE 72 EUROPE OTHER TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 140
TABLE 73 EUROPE PULMONARY DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 140
TABLE 74 EUROPE NEBULIZERS PULMONARY DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 141
TABLE 75 EUROPE DRUG DELIVERY MARKET, BY END USERS, 2015 – 2024 (USD BILLION) 141
TABLE 76 EUROPE DRUG DELIVERY MARKET,BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) 142
TABLE 77 GERMANY DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2017 – 2024 (USD BILLION) 144
TABLE 78 GERMANY ORAL DRUG DELIVERY MARKET, BY FORM, 2017 – 2024 (USD BILLION) 145
TABLE 79 GERMANY SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 145
TABLE 80 GERMANY LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 146
TABLE 81 GERMANY SEMI-SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 146
TABLE 82 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 147
TABLE 83 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 147
TABLE 84 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2017 – 2024 (USD BILLION) 148
TABLE 85 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 148
TABLE 86 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2017 – 2024 (USD BILLION) 149
TABLE 87 GERMANY SELF INJECTION DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 149
TABLE 88 GERMANY INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 150
TABLE 89 GERMANY OPHTHALMIC DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 150
TABLE 90 GERMANY OCCULAR DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 151
TABLE 91 GERMANY OCCULAR DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2017 – 2024 (USD BILLION) 151
TABLE 92 GERMANY LIQUID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY FORM, 2017 – 2024 (USD BILLION) 152
TABLE 93 GERMANY SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS MARKET
BY FORM, 2017 – 2024 (USD BILLION) 152
TABLE 94 GERMANY NASAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 153
TABLE 95 GERMANY TOPICAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 153
TABLE 96 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 154
TABLE 97 GERMANY TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2017 – 2024 (USD BILLION) 154
TABLE 98 GERMANY SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2017 – 2024 (USD BILLION) 155
TABLE 99 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2014 – 2022 (USD BILLION) 155
TABLE 1 LIST OF FDA APPROVED BIOLOGICS, IN 2016 48
TABLE 2 LIST OF FDA APPROVED GENERICS, IN 2016 52
TABLE 3 MAJOR PRODUCT RECALLS IN THE DRUG DELIVERY MARKET, 2016 54
TABLE 4 PATENT EXPIRY OF DRUGS, 2015-2017 56
TABLE 5 EUROPE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2015 – 2024 (USD BILLION) 65
TABLE 6 EUROPE ORAL DRUG DELIVERY MARKET, BY FORM, 2015 – 2024 (USD BILLION) 66
TABLE 7 EUROPE SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 68
TABLE 8 EUROPE LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 70
TABLE 9 EUROPE SEMI-SOLID ORAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 71
TABLE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 72
TABLE 11 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 72
TABLE 12 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2015 – 2024 (USD BILLION) 73
TABLE 13 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 73
TABLE 14 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2015 – 2024 (USD BILLION) 74
TABLE 15 EUROPE SELF INJECTION DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 74
TABLE 16 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 75
TABLE 17 EUROPE PULMONARY DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 77
TABLE 18 EUROPE NEBULIZERS DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 79
TABLE 19 EUROPE INJECTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 81
TABLE 20 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 82
TABLE 21 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2015 – 2024 (USD BILLION) 85
TABLE 22 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 85
TABLE 23 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2015 – 2024 (USD BILLION) 86
TABLE 24 EUROPE SELF INJECTION DRUG DELIVERY DEVICES MARKET,
BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 89
TABLE 25 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 91
TABLE 26 EUROPE OPHTHALMIC DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 92
TABLE 27 EUROPE OCCULAR DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 94
TABLE 28 EUROPE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 94
TABLE 29 EUROPE SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 95
TABLE 30 EUROPE OCCULAR DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 97
TABLE 31 EUROPE NASAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 99
TABLE 32 EUROPE TOPICAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 100
TABLE 33 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE,2015 – 2024 (USD BILLION) 102
TABLE 34 EUROPE TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 103
TABLE 35 EUROPE SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 104
TABLE 36 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 106
TABLE 37 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 107
TABLE 38 EUROPE IMPLANTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 109
TABLE 39 EUROPE TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 111
TABLE 40 EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 112
TABLE 41 EUROPE OTHER TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 114
TABLE 42 EUROPE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD MILLION) 116
TABLE 43 EUROPE DRUG DELIVERY MARKET, BY END USER, 2015 – 2027 (USD BILLION) 119
TABLE 44 EUROPE DRUG DELIVERY MARKET, BY COUNTRY, 2015 – 2024 (USD BILLION) 124
TABLE 45 EUROPE DRUG DELIVERY MARKET, BY ROUTE OF ADMINISTRATION, 2015 – 2024 (USD BILLION) 126
TABLE 46 EUROPE ORAL DRUG DELIVERY MARKET, BY FORM, 2015 – 2024 (USD BILLION) 127
TABLE 47 EUROPE SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 127
TABLE 48 EUROPE LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 128
TABLE 49 EUROPE SEMI-SOLID ORAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 128
TABLE 50 EUROPE INJECTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 129
TABLE 51 EUROPE INJECTABLE DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 129
TABLE 52 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2015 – 2024 (USD BILLION) 130
TABLE 53 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 130
TABLE 54 EUROPE CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2015 – 2024 (USD BILLION) 131
TABLE 55 EUROPE SELF INJECTION DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 131
TABLE 56 EUROPE INJECTABLE DRUG DELIVERY FORMULATIONS MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 132
TABLE 57 EUROPE OPHTHALMIC DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 132
TABLE 58 EUROPE OCCULAR DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 133
TABLE 59 EUROPE OPHTHALMIC DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 133
TABLE 60 EUROPE LIQUID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 134
TABLE 61 EUROPE SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 134
TABLE 62 EUROPE NASAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 135
TABLE 63 EUROPE TOPICAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 135
TABLE 64 EUROPE TRANSDERMAL DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 136
TABLE 65 EUROPE TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2015 – 2024 (USD BILLION) 136
TABLE 66 EUROPE SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2015 – 2024 (USD BILLION) 137
TABLE 67 EUROPE LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY TYPE, 2015 – 2024 (USD BILLION) 137
TABLE 68 EUROPE SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY TYPE, 2015 – 2024 (USD BILLION) 138
TABLE 69 EUROPE IMPLANTABLE DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 138
TABLE 70 EUROPE TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 139
TABLE 71 EUROPE ORAL TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 139
TABLE 72 EUROPE OTHER TRANSMUCOSAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 140
TABLE 73 EUROPE PULMONARY DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 140
TABLE 74 EUROPE NEBULIZERS PULMONARY DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2015 – 2024 (USD BILLION) 141
TABLE 75 EUROPE DRUG DELIVERY MARKET, BY END USERS, 2015 – 2024 (USD BILLION) 141
TABLE 76 EUROPE DRUG DELIVERY MARKET,BY DISTRIBUTION CHANNEL, 2015 – 2024 (USD BILLION) 142
TABLE 77 GERMANY DRUG DELIVERY DEVICES MARKET, BY ROUTE OF ADMINISTRATION, 2017 – 2024 (USD BILLION) 144
TABLE 78 GERMANY ORAL DRUG DELIVERY MARKET, BY FORM, 2017 – 2024 (USD BILLION) 145
TABLE 79 GERMANY SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 145
TABLE 80 GERMANY LIQUID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 146
TABLE 81 GERMANY SEMI-SOLID ORAL DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 146
TABLE 82 GERMANY INJECTABLE DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 147
TABLE 83 GERMANY INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 147
TABLE 84 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY MATERIAL, 2017 – 2024 (USD BILLION) 148
TABLE 85 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 148
TABLE 86 GERMANY CONVENTIONAL INJECTABLE DRUG DELIVERY DEVICES MARKET, BY USABILITY, 2017 – 2024 (USD BILLION) 149
TABLE 87 GERMANY SELF INJECTION DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 149
TABLE 88 GERMANY INJECTABLE DRUG DELIVERY FORMULATIONS MARKET, BY PRODUCT TYPE, 2014 – 2022 (USD BILLION) 150
TABLE 89 GERMANY OPHTHALMIC DRUG DELIVERY MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 150
TABLE 90 GERMANY OCCULAR DRUG DELIVERY DEVICES MARKET,BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 151
TABLE 91 GERMANY OCCULAR DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2017 – 2024 (USD BILLION) 151
TABLE 92 GERMANY LIQUID OCCULAR DRUG DELIVERY FORMULATIONS MARKET, BY FORM, 2017 – 2024 (USD BILLION) 152
TABLE 93 GERMANY SEMI SOLID OCCULAR DRUG DELIVERY FORMULATIONS MARKET
BY FORM, 2017 – 2024 (USD BILLION) 152
TABLE 94 GERMANY NASAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 153
TABLE 95 GERMANY TOPICAL DRUG DELIVERY MARKET,BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 153
TABLE 96 GERMANY TRANSDERMAL DRUG DELIVERY DEVICES MARKET, BY PRODUCT TYPE, 2017 – 2024 (USD BILLION) 154
TABLE 97 GERMANY TOPICAL DRUG DELIVERY FORMULATIONS MARKET,BY FORM, 2017 – 2024 (USD BILLION) 154
TABLE 98 GERMANY SEMI SOLID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2017 – 2024 (USD BILLION) 155
TABLE 99 GERMANY LIQUID TOPICAL DRUG DELIVERY FORMULATIONS MARKET, BY TYPE, 2014 – 2022 (USD BILLION) 155
LIST OF FIGURES
FIGURE 1 EUROPE DRUG DELIVERY MARKET: SEGMENTATION 38
FIGURE 2 EUROPE DRUG DELIVERY MARKET: GEOGRAHIC SCOPE 39
FIGURE 3 EUROPE DRUG DELIVERY MARKET: DATA TRIANGULATION 41
FIGURE 4 EUROPE DRUG DELIVERY MARKET: RESEARCH SNAPSHOT 42
FIGURE 5 EUROPE DRUG DELIVERY MARKET: BOTTOM UP APPROACH 43
FIGURE 6 EUROPE DRUG DELIVERY MARKET: TOP DOWN APPROACH 43
FIGURE 7 EUROPE DRUG DELIVERY MARKET: INTERVIEWS BY REGION AND DESIGNATION 44
FIGURE 8 GERMANY DOMINATES THE MARKET FOR DRUG DELIVERY AND FRANCE IS EXPECTED TO CONTINUE THIS TREND IN THE FORECAST PERIOD TO 2024 59
FIGURE 9 TECHNOLOGICAL DEVELOPMENT IN SELF ADMINISTERED AND NON-INVASIVE DRUG DELIVERY TECHNOLOGIES IS EXPECTED TO DRIVE THE MARKET FOR EUROPE DRUG DELIVERY IN THE FORECAST PERIOD 2017 TO 2024 60
FIGURE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DRUG DELIVERY MARKET IN 2024 61
FIGURE 11 FRANCE AND SWITZERLAND ARE THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR DRUG DELIVERY MANUFACTURERS IN THE FORECAST PERIOD 2015 TO 2024 62
FIGURE 12 EUROPE DRUG DELIVERY MARKET: BY ROUTE OF ADMINISTRATION, SNAPSHOT 2016 64
FIGURE 13 EUROPE DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016 115
FIGURE 14 EUROPE DRUG DELIVERY MARKET: BY END-USER, SNAPSHOT 2016 118
FIGURE 15 EUROPE DRUG DELIVERY MARKET: BY GEOGRAPHY, 2016 121
FIGURE 16 EUROPE DRUG DELIVERY MARKET: BY COUNTRY, SNAPSHOT 2016 & 2024 123
FIGURE 17 EUROPE INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN EUROPE DRUG DELIVERY MARKET 125
FIGURE 18 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN GERMANY DRUG DELIVERY MARKET 143
FIGURE 19 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN U.K. DRUG DELIVERY MARKET 161
FIGURE 20 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN FRANCE DRUG DELIVERY MARKET 179
FIGURE 21 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN ITALY DRUG DELIVERY MARKET 197
FIGURE 22 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN RUSSIA DRUG DELIVERY DEVICES MARKET 215
FIGURE 23 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN TURKEY DRUG DELIVERY MARKET 233
FIGURE 24 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN SWITZERLAND DRUG DELIVERY MARKET 250
FIGURE 25 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN BELGIUM DRUG DELIVERY DEVICES MARKET 268
FIGURE 26 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN SPAIN DRUG DELIVERY DEVICES MARKET 285
FIGURE 27 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN NETHERLANDS DRUG DELIVERY MARKET 303
FIGURE 28 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN REST OF EUROPE DRUG DELIVERY MARKET 321
FIGURE 29 EUROPE DRUG DELIVERY MARKET: COMPANY SHARE 2016 (%) 323
FIGURE 1 EUROPE DRUG DELIVERY MARKET: SEGMENTATION 38
FIGURE 2 EUROPE DRUG DELIVERY MARKET: GEOGRAHIC SCOPE 39
FIGURE 3 EUROPE DRUG DELIVERY MARKET: DATA TRIANGULATION 41
FIGURE 4 EUROPE DRUG DELIVERY MARKET: RESEARCH SNAPSHOT 42
FIGURE 5 EUROPE DRUG DELIVERY MARKET: BOTTOM UP APPROACH 43
FIGURE 6 EUROPE DRUG DELIVERY MARKET: TOP DOWN APPROACH 43
FIGURE 7 EUROPE DRUG DELIVERY MARKET: INTERVIEWS BY REGION AND DESIGNATION 44
FIGURE 8 GERMANY DOMINATES THE MARKET FOR DRUG DELIVERY AND FRANCE IS EXPECTED TO CONTINUE THIS TREND IN THE FORECAST PERIOD TO 2024 59
FIGURE 9 TECHNOLOGICAL DEVELOPMENT IN SELF ADMINISTERED AND NON-INVASIVE DRUG DELIVERY TECHNOLOGIES IS EXPECTED TO DRIVE THE MARKET FOR EUROPE DRUG DELIVERY IN THE FORECAST PERIOD 2017 TO 2024 60
FIGURE 10 EUROPE INJECTABLE DRUG DELIVERY MARKET SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE DRUG DELIVERY MARKET IN 2024 61
FIGURE 11 FRANCE AND SWITZERLAND ARE THE HIGHEST GROWING AND MOST PROFITABLE REVENUE POCKETS FOR DRUG DELIVERY MANUFACTURERS IN THE FORECAST PERIOD 2015 TO 2024 62
FIGURE 12 EUROPE DRUG DELIVERY MARKET: BY ROUTE OF ADMINISTRATION, SNAPSHOT 2016 64
FIGURE 13 EUROPE DRUG DELIVERY MARKET: BY DISTRIBUTION CHANNEL, SNAPSHOT 2016 115
FIGURE 14 EUROPE DRUG DELIVERY MARKET: BY END-USER, SNAPSHOT 2016 118
FIGURE 15 EUROPE DRUG DELIVERY MARKET: BY GEOGRAPHY, 2016 121
FIGURE 16 EUROPE DRUG DELIVERY MARKET: BY COUNTRY, SNAPSHOT 2016 & 2024 123
FIGURE 17 EUROPE INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN EUROPE DRUG DELIVERY MARKET 125
FIGURE 18 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN GERMANY DRUG DELIVERY MARKET 143
FIGURE 19 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN U.K. DRUG DELIVERY MARKET 161
FIGURE 20 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN FRANCE DRUG DELIVERY MARKET 179
FIGURE 21 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN ITALY DRUG DELIVERY MARKET 197
FIGURE 22 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN RUSSIA DRUG DELIVERY DEVICES MARKET 215
FIGURE 23 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN TURKEY DRUG DELIVERY MARKET 233
FIGURE 24 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN SWITZERLAND DRUG DELIVERY MARKET 250
FIGURE 25 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN BELGIUM DRUG DELIVERY DEVICES MARKET 268
FIGURE 26 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN SPAIN DRUG DELIVERY DEVICES MARKET 285
FIGURE 27 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN NETHERLANDS DRUG DELIVERY MARKET 303
FIGURE 28 INJECTABLE DRUG DELIVERY IS EXPECTED TO BE GROWING AT THE HIGHEST CAGR IN THE FORECAST PERIOD IN REST OF EUROPE DRUG DELIVERY MARKET 321
FIGURE 29 EUROPE DRUG DELIVERY MARKET: COMPANY SHARE 2016 (%) 323
